TPD52 and prostate adenocarcinoma: We discovered that TPD52 in PRAD samples was hypomethylation compared with adjacent normal ones, which is consistent with the observed upregulation of TPD52 in PRAD combined with DNA methyltransferase analysis (DNMT1, DNMT3A and DMNT3B).